JHSM

Journal of Health Sciences and Medicine (JHSM) is an unbiased, peer-reviewed, and open access international medical journal. The Journal publishes interesting clinical and experimental research conducted in all fields of medicine, interesting case reports, and clinical images, invited reviews, editorials, letters, comments, and related knowledge.

EndNote Style
Index
Original Article
Comparative assessment of patients' admission to urology departments during and before the COVID-19 pandemic: a retrospective cohort study
Aims: To determine the diseases that presented to the urology department during the COVID-19 pandemic and for hospital-based comparison with the diseases that presented in the same period of the previous year. Material and
Methods: In this retrospective follow-up study, patients who were admitted to the tertiary university hospital and secondary state hospital urology departments between April-July 2019 and April-July 2020 were included in the study. We searched the health administrative data using the International Classification of Diseases-10 codes. The number and variety of patients who were admitted to the urology departments in the same months of 2019 and 2020 were compared.
Results: In both hospitals, the total number of admissions decreased during the pandemic in 2020 compared to the pre-pandemic year. Also, elective admissions decreased in 2020 compared to the pre-pandemic year (p <0.001). In a significant part of the urological disease group, the decrease in the number of admissions was found to be higher for the second-level center than for the tertiary center hospital.
Conclusion: We documented that uro-oncology outpatient admissions could continue during the COVID-19 pandemic in a university hospital- not primarily served as a pandemic hospital- by taking preventive measures and prioritizing healthcare personnel and patient safety.


1. Huang C, Wang Y, Li X, Ren L, et al. Clinical features of patientsinfected with 2019 novel coronavirus in Wuhan, China. Lancet2020; 395: 497-506.
2. Stensland KD, Morgan TM, Moinzadeh A, et al. Considerations inthe triage of urologic surgeries during the COVID-19 pandemic.Eur Urol 2020; 77: 663-6.
3. Ribal MJ, Cornford P, Briganti A, et al. European Associationof Urology Guidelines Office Rapid Reaction Group: AnOrganisation-wide Collaborative Effort to Adapt the EuropeanAssociation of Urology Guidelines Recommendations to theCoronavirus Disease 2019 Era. Eur Urol 2020;78: 21-8.
4. Coronavirus Disease (COVID-19) Situation Reports [Internet].[cited 2021 Mar 28]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports.
5. Wong J, Goh QY, Tan Z, et al. Preparing for a COVID-19 pandemic:a review of operating room outbreak response measures in a largetertiary hospital in Singapore. Can J Anaesth 2020; 67: 732-45.
6. Keles E, Akis S, Kemal Ozturk U, Eser Ozyurek S, Api M.Gynecological surgeries during the COVID-19 pandemic inTurkey. Int J Gynaecol Obstet 2020; 151: 141-4.
7. Tefik T, Guven S, Villa L, et al. Urolithiasis Practice PatternsFollowing the COVID-19 Pandemic: Overview from the EULISCollaborative Research Working Group. Eur Urol 2020; 78: e21-4.
8. Proietti S, Gaboardi F, Giusti G. Endourological stone managementin the era of the COVID-19. Eur Urol 2020; 78: 131-3.
9. Puliatti S, Eissa A, Eissa R, et al. COVID-19 and urology: acomprehensive review of the literature. BJU Int 2020; 125: E7-E14.
10. Flammia S, Salciccia S, Tufano A, Busetto GM, Ricciuti GP,Sciarra A. How urinary stone emergencies changed in the time ofCOVID-19? Urolithiasis 2020; 48: 467-9.
11. Al-Shamsi HO, Alhazzani W, Alhuraiji A, et al. A practicalapproach to the management of cancer patients during the novelcoronavirus disease 2019 (COVID-19) pandemic: an internationalcollaborative group. Oncologist 2020; 25: 936-45.
12. Liang W, Guan W, Chen R, et al. Cancer patients in SARS-CoV-2infection: a nationwide analysis in China. Lancet Oncol 2020; 21:335-7.
13. Wang H, Zhang L. Risk of COVID-19 for patients with cancer.Lancet Oncol 2020; 21: e181.
14. Zequi SC, Abreu D. Consideration in the management of renalcell carcinoma during the COVID-19 pandemic. Int Braz J Urol2020; 46: 69-78.
15. Gravas S, Fournier G, Oya M, et al. Prioritising Urological Surgeryin the COVID-19 Era: A Global Reflection on Guidelines. EurUrol Focus 2020; 6: 1104-10.
16. Professionals S-O. EAU Guidelines: Non-muscle-invasive BladderCancer [Internet]. Uroweb. [cited 2020 Dec 5]. Available from:https://uroweb.org/guideline/non-muscle-invasive-bladder-cancer/
17. Esperto F, Pang KH, Albisinni S, Papalia R, Scarpa RM. Bladdercancer at the time of COVID-19 outbreak. Int Braz J Urol 2020;46: 62-8.
18. Darlington CD, Mammen RJ, Mammen KJ. COVID-19 and itsimpact on genitourinary malignancies. Indian J Urol 2020; 36:163-170.
19. Carneiro A, Wroclawski ML, Nahar B, et al. Impact of theCOVID-19 pandemic on the urologist&rsquo;s clinical practice in Brazil:a management guideline proposal for low- and middle-incomecountries during the crisis period. Int Braz J Urol 2020; 46: 501-10.
20. Nappi L, Ottaviano M, Rescigno P, et al. Italian Germ Cell CancerGroup (IGG) ERN-EURACAN Domain G3 GenitourinaryMedical Oncologists of Canada (GUMOC) Management ofgerm cell tumors during the outbreak of the novel coronavirusdisease-19 pandemic: a survey of international expertise centers.Oncologist 2020; 25: 1509-15.
21. Bozkurt O, Sen V, Irer B, et al. Nation-wide analysis of the impactof the Covid-19 pandemic on daily urology practice in Turkey. IntJ Clin Pract 2021; 75: e13735.
22. Icarra V, Novara G, Abrate A, et al. Urology practice during theCOVID-19 pandemic. Minerva Urol Nefrol 2020; 72: 369-75.
23. Karag&ouml;z MA, G&uuml;l A, Borg C, et al. Influence of COVID-19pandemic on sexuality: a cross-sectional study among couples inTurkey. Int J Impot Res 2020; 33: 815-23.
Volume 6, Issue 2, 2023
Page : 410-415
_Footer